Current status and future perspectives of HLA-edited induced pluripotent stem cells
Abstract In 2007, Human-induced pluripotent stem cells (iPSCs) were generated by transducing four genes (Oct3/4, Sox2, Klf4, c-Myc). Because iPSCs can differentiate into any types of cells in the body and have fewer ethical issues compared to embryonic stem (ES) cells, application of iPSCs for regen...
Main Authors: | Keiko Koga, Bo Wang, Shin Kaneko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Inflammation and Regeneration |
Online Access: | http://link.springer.com/article/10.1186/s41232-020-00132-9 |
Similar Items
-
Induced pluripotent stem cells for cartilage repair: status and future perspectives
by: R Castro-Viñuelas, et al.
Published: (2018-09-01) -
Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018) -
Pluripotent Stem Cells: Current Understanding and Future Directions
by: Antonio Romito, et al.
Published: (2016-01-01) -
Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
by: Liu Zhiqiang, et al.
Published: (2013-01-01) -
Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
by: Weiwei Zhang, et al.
Published: (2016-01-01)